{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:57:33Z","timestamp":1783519053831,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-10040-7","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:17:10Z","timestamp":1730305030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting"],"prefix":"10.1007","volume":"51","author":[{"given":"Pooja","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibekanand","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"1","key":"10040_CR1","first-page":"25","volume":"19","author":"C Wang","year":"2016","unstructured":"Wang C et al (2016) Molecular mechanisms of chemoresistance in oral cancer. Chin J Dent Res 19(1):25\u201333","journal-title":"Chin J Dent Res"},{"key":"10040_CR2","doi-asserted-by":"crossref","unstructured":"Xie S et al (2024) A Tumor-promotional Molecular Axis CircMAPKBP1\/miR-17-3p\/TGF\u03b22 Activates Autophagy Pathway to Drive Tongue Squamous Cell Carcinoma Cisplatin Chemoresistance. Cancer Letters, : p. 217230","DOI":"10.1016\/j.canlet.2024.217230"},{"issue":"12","key":"10040_CR3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jamaoncol.2016.1804","volume":"2","author":"ZS Zumsteg","year":"2016","unstructured":"Zumsteg ZS et al (2016) Incidence of oropharyngeal cancer among elderly patients in the United States. JAMA Oncol 2(12):1617\u20131623","journal-title":"JAMA Oncol"},{"issue":"1","key":"10040_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcrt.JCRT_763_17","volume":"14","author":"G Han","year":"2018","unstructured":"Han G, Xu C, Yu D (2018) Mechanisms correlated with chemotherapy resistance in tongue cancers. J Cancer Res Ther 14(1):1\u20135","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"10040_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/pharmaceutics11070302","volume":"11","author":"F Ketabat","year":"2019","unstructured":"Ketabat F et al (2019) Controlled drug delivery systems for oral cancer treatment\u2014current status and future perspectives. Pharmaceutics 11(7):302","journal-title":"Pharmaceutics"},{"key":"10040_CR6","doi-asserted-by":"crossref","first-page":"644718","DOI":"10.3389\/fphar.2021.644718","volume":"12","author":"Z Tian","year":"2021","unstructured":"Tian Z et al (2021) Insight into the prospects for RNAi therapy of cancer. Front Pharmacol 12:644718","journal-title":"Front Pharmacol"},{"key":"10040_CR7","doi-asserted-by":"crossref","first-page":"146919","DOI":"10.1016\/j.gene.2022.146919","volume":"849","author":"T Chattopadhyay","year":"2023","unstructured":"Chattopadhyay T et al (2023) Genome-wide profiling of dysregulated piRNAs and their target genes implicated in oncogenicity of tongue squamous cell carcinoma. Gene 849:146919","journal-title":"Gene"},{"issue":"9","key":"10040_CR8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1039\/D3MO00098B","volume":"19","author":"P Gupta","year":"2023","unstructured":"Gupta P et al (2023) TarpiD, a database of putative and validated targets of piRNAs. Mol Omics 19(9):706\u2013713","journal-title":"Mol Omics"},{"issue":"3","key":"10040_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mc.22932","volume":"58","author":"B Das","year":"2019","unstructured":"Das B et al (2019) Tumor suppressive activity of PIWI-interacting RNA in human fibrosarcoma mediated through repression of RRM2. Mol Carcinog 58(3):344\u2013357","journal-title":"Mol Carcinog"},{"key":"10040_CR10","doi-asserted-by":"crossref","first-page":"121954","DOI":"10.1016\/j.lfs.2023.121954","volume":"329","author":"T Chattopadhyay","year":"2023","unstructured":"Chattopadhyay T, Mallick B (2023) FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma. Life Sci 329:121954","journal-title":"Life Sci"},{"key":"10040_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.omtn.2020.06.006","volume":"21","author":"CM Ferguson","year":"2020","unstructured":"Ferguson CM et al (2020) Cell type impacts accessibility of mRNA to silencing by RNA interference. Mol Therapy-Nucleic Acids 21:384\u2013393","journal-title":"Mol Therapy-Nucleic Acids"},{"issue":"3","key":"10040_CR12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1039\/D2MO00245K","volume":"19","author":"R Nayak","year":"2023","unstructured":"Nayak R et al (2023) Integrative analysis of small non-coding RNAs predicts a piRNA\/miRNA-CCND1\/BRAF\/HRH1\/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma. Mol Omics 19(3):252\u2013261","journal-title":"Mol Omics"},{"issue":"5","key":"10040_CR13","first-page":"4588","volume":"8","author":"Y Ren","year":"2015","unstructured":"Ren Y et al (2015) MiRNA-139 regulates oral cancer Tca8113 cells apoptosis through akt signaling pathway. Int J Clin Exp Pathol 8(5):4588","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10040_CR14","first-page":"1","volume":"21","author":"Z Xin","year":"2021","unstructured":"Xin Z et al (2021) MicroRNA-145-5p aggravates cell apoptosis and oxidative stress in tongue squamous cell carcinoma. Experimental Therapeutic Med 21(4):1\u20138","journal-title":"Experimental Therapeutic Med"},{"issue":"1","key":"10040_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Therapy 1(1):1\u20139","journal-title":"Signal Transduct Target Therapy"},{"key":"10040_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.03.017","volume":"57","author":"Q He","year":"2016","unstructured":"He Q et al (2016) microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol 57:15\u201320","journal-title":"Oral Oncol"},{"key":"10040_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00784-017-2126-y","volume":"22","author":"G Supic","year":"2018","unstructured":"Supic G et al (2018) miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients. Clin Oral Invest 22:401\u2013409","journal-title":"Clin Oral Invest"},{"key":"10040_CR18","doi-asserted-by":"crossref","first-page":"103750","DOI":"10.1016\/j.dnarep.2024.103750","volume":"142","author":"P Biswal","year":"2024","unstructured":"Biswal P, Mallick B (2024) miR-185\u20135p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9. DNA Repair 142:103750","journal-title":"DNA Repair"},{"key":"10040_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13402-015-0259-z","volume":"39","author":"MB Duz","year":"2016","unstructured":"Duz MB et al (2016) Identification of mir-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol 39:187\u2013193","journal-title":"Cell Oncol"},{"key":"10040_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0606-9","volume":"11","author":"W Si","year":"2019","unstructured":"Si W et al (2019) The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics 11:1\u201324","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10040_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/03009734.2018.1439551","volume":"123","author":"K Zeljic","year":"2018","unstructured":"Zeljic K et al (2018) MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. Ups J Med Sci 123(1):43\u201349","journal-title":"Ups J Med Sci"},{"issue":"6","key":"10040_CR22","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/or.2015.3936","volume":"33","author":"C-Y Huang","year":"2015","unstructured":"Huang C-Y et al (2015) Mir-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncol Rep 33(6):2889\u20132898","journal-title":"Oncol Rep"},{"key":"10040_CR23","doi-asserted-by":"crossref","unstructured":"Zhao J, Li D, Fang L (2019) MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1, vol 115. Biomedicine & Pharmacotherapy, p 108947","DOI":"10.1016\/j.biopha.2019.108947"},{"issue":"4","key":"10040_CR24","first-page":"2921","volume":"17","author":"L Huo","year":"2019","unstructured":"Huo L et al (2019) miR\u2013128\u20133p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS\u20131\/PI3K\/AKT signaling pathway. Experimental Therapeutic Med 17(4):2921\u20132930","journal-title":"Experimental Therapeutic Med"},{"issue":"1","key":"10040_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12957-023-02906-0","volume":"21","author":"X Du","year":"2023","unstructured":"Du X et al (2023) microRNA-128-3p inhibits proliferation and accelerates apoptosis of gastric cancer cells via inhibition of TUFT1. World J Surg Oncol 21(1):47","journal-title":"World J Surg Oncol"},{"key":"10040_CR26","doi-asserted-by":"crossref","first-page":"108966","DOI":"10.1016\/j.biopha.2019.108966","volume":"116","author":"J Chen","year":"2019","unstructured":"Chen J, Zhao D, Meng Q (2019) Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor mir-128-3p in anaplastic thyroid cancer. Biomed Pharmacother 116:108966","journal-title":"Biomed Pharmacother"},{"key":"10040_CR27","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.7717\/peerj.12802","volume":"10","author":"T Zheng","year":"2022","unstructured":"Zheng T et al (2022) Functional mechanism of hsa-mir-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. PeerJ 10:e12802","journal-title":"PeerJ"},{"issue":"1","key":"10040_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/10717544.2020.1716882","volume":"27","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) Nanocomplexes loaded with mir-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K\/AKT and MEK\/ERK pathway. Drug Delivery 27(1):323\u2013333","journal-title":"Drug Delivery"},{"key":"10040_CR29","doi-asserted-by":"crossref","first-page":"568738","DOI":"10.3389\/fcell.2021.568738","volume":"9","author":"J Bai","year":"2021","unstructured":"Bai J et al (2021) Exosomal mir-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-\u03b2\/SMAD and JAK\/STAT3 signaling. Front cell Dev Biology 9:568738","journal-title":"Front cell Dev Biology"},{"key":"10040_CR30","first-page":"p17588359198755","volume":"11","author":"JG Park","year":"2019","unstructured":"Park JG, Aziz N, Cho JY (2019) MKK7, the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target. Therapeutic Adv Med Oncol 11:p1758835919875574","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"2","key":"10040_CR31","first-page":"1379","volume":"15","author":"Q Peng","year":"2018","unstructured":"Peng Q et al (2018) Mitogen-activated protein kinase signaling pathway in oral cancer. Oncol Lett 15(2):1379\u20131388","journal-title":"Oncol Lett"},{"issue":"8","key":"10040_CR32","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.7150\/ijbs.79163","volume":"19","author":"F Yang","year":"2023","unstructured":"Yang F et al (2023) Inhibition of JNK\/c-Jun-ATF2 overcomes cisplatin resistance in liver cancer through down-regulating galectin-1. Int J Biol Sci 19(8):2366","journal-title":"Int J Biol Sci"},{"key":"10040_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2010-11-8-r90","volume":"11","author":"D Betel","year":"2010","unstructured":"Betel D et al (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11:1\u201314","journal-title":"Genome Biol"},{"key":"10040_CR34","doi-asserted-by":"crossref","unstructured":"Wu M et al (2020) MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2, vol 122. Biomedicine & Pharmacotherapy, p 109696","DOI":"10.1016\/j.biopha.2019.109696"},{"issue":"1","key":"10040_CR35","doi-asserted-by":"crossref","first-page":"23932","DOI":"10.1038\/srep23932","volume":"6","author":"RD Ghosh","year":"2016","unstructured":"Ghosh RD et al (2016) MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features. Sci Rep 6(1):23932","journal-title":"Sci Rep"},{"key":"10040_CR36","doi-asserted-by":"crossref","unstructured":"Cl\u00e9ment T, Salone V, Rederstorff M (2015) Dual luciferase gene reporter assays to study miRNA function. Small non-coding RNAs: methods and protocols, pp. 187\u2013198","DOI":"10.1007\/978-1-4939-2547-6_17"},{"issue":"46","key":"10040_CR37","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D et al (2021) A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40(46):6395\u20136405","journal-title":"Oncogene"},{"key":"10040_CR38","doi-asserted-by":"crossref","unstructured":"Zhu MM et al (2012) Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.","DOI":"10.1371\/journal.pone.0041763"},{"issue":"6","key":"10040_CR39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/bfgp\/elac031","volume":"21","author":"P Gupta","year":"2022","unstructured":"Gupta P, Chattopadhyay T, Mallick B (2022) miRNome-transcriptome analysis unveils the key regulatory pathways involved in the tumorigenesis of tongue squamous cell carcinoma. Brief Funct Genomics 21(6):466\u2013477","journal-title":"Brief Funct Genomics"},{"issue":"6","key":"10040_CR40","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T (2020) Epithelial-mesenchymal transition in cancer: a historical overview. Translational Oncol 13(6):100773","journal-title":"Translational Oncol"},{"key":"10040_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0076-6879(08)01606-6","volume":"446","author":"D Plesca","year":"2008","unstructured":"Plesca D, Mazumder S, Almasan A (2008) DNA damage response and apoptosis. Methods Enzymol 446:107\u2013122","journal-title":"Methods Enzymol"},{"issue":"19","key":"10040_CR42","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1007\/s00432-023-05473-9","volume":"149","author":"J Yu","year":"2023","unstructured":"Yu J et al (2023) Components of the JNK\u2013MAPK pathway play distinct roles in hepatocellular carcinoma. J Cancer Res Clin Oncol 149(19):17495\u201317509","journal-title":"J Cancer Res Clin Oncol"},{"key":"10040_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0475-z","volume":"12","author":"Y Dou","year":"2019","unstructured":"Dou Y et al (2019) The Jun N-terminal kinases signaling pathway plays a seesaw role in ovarian carcinoma: a molecular aspect. J Ovarian Res 12:1\u201311","journal-title":"J Ovarian Res"},{"issue":"7056","key":"10040_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nature03914","volume":"437","author":"AS Nateri","year":"2005","unstructured":"Nateri AS, Spencer-Dene B, Behrens A (2005) Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437(7056):281\u2013285","journal-title":"Nature"},{"key":"10040_CR45","doi-asserted-by":"crossref","first-page":"761379","DOI":"10.3389\/fonc.2021.761379","volume":"11","author":"Y Cheng","year":"2021","unstructured":"Cheng Y et al (2021) The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma. Front Oncol 11:761379","journal-title":"Front Oncol"},{"issue":"1","key":"10040_CR46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2012.07.003","volume":"136","author":"SM Sancho-Mart\u00ednez","year":"2012","unstructured":"Sancho-Mart\u00ednez SM et al (2012) Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 136(1):35\u201355","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10040_CR47","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41598-020-65331-3","volume":"10","author":"C Zhao","year":"2020","unstructured":"Zhao C et al (2020) MicroRNA-128-3p enhances the chemosensitivity of temozolomide in glioblastoma by targeting c-Met and EMT. Sci Rep 10(1):9471","journal-title":"Sci Rep"},{"key":"10040_CR48","doi-asserted-by":"crossref","first-page":"1067974","DOI":"10.3389\/fonc.2022.1067974","volume":"12","author":"HS Budi","year":"2023","unstructured":"Budi HS et al (2023) The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. Front Oncol 12:1067974","journal-title":"Front Oncol"},{"issue":"1","key":"10040_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apsb.2016.09.002","volume":"7","author":"X An","year":"2017","unstructured":"An X et al (2017) Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sinica B 7(1):38\u201351","journal-title":"Acta Pharm Sinica B"},{"issue":"4","key":"10040_CR50","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4149\/neo_2016_411","volume":"63","author":"M Janikova","year":"2016","unstructured":"Janikova M et al (2016) Prognostic significance of miR-23b in combination with P-gp, MRP and LRP\/MVP expression in non-small cell lung cancer. Neoplasma 63(4):576\u2013587","journal-title":"Neoplasma"},{"issue":"2","key":"10040_CR51","first-page":"451","volume":"55","author":"LM Deng","year":"2019","unstructured":"Deng LM et al (2019) miR\u20131 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells. Int J Oncol 55(2):451\u2013461","journal-title":"Int J Oncol"},{"issue":"22","key":"10040_CR52","doi-asserted-by":"crossref","first-page":"13857","DOI":"10.3390\/ijms232213857","volume":"23","author":"C-C Su","year":"2022","unstructured":"Su C-C et al (2022) Involvement of AMPK\u03b1 and MAPK-ERK\/-JNK signals in docetaxel-induced human tongue squamous cell carcinoma cell apoptosis. Int J Mol Sci 23(22):13857","journal-title":"Int J Mol Sci"},{"key":"10040_CR53","doi-asserted-by":"crossref","first-page":"105698","DOI":"10.1016\/j.archoralbio.2023.105698","volume":"151","author":"GM Al-Ashmawy","year":"2023","unstructured":"Al-Ashmawy GM et al (2023) Cancer chemo-preventive role of grape seed oil and cisplatin as a combination adjuvant therapy in the treatment of tongue squamous cell carcinoma: a biological in-vitro study. Arch Oral Biol 151:105698","journal-title":"Arch Oral Biol"},{"key":"10040_CR54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.oraloncology.2017.02.015","volume":"67","author":"OF Karatas","year":"2017","unstructured":"Karatas OF et al (2017) MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications. Oral Oncol 67:124\u2013130","journal-title":"Oral Oncol"},{"issue":"1","key":"10040_CR55","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s42003-021-02844-1","volume":"4","author":"B Das","year":"2021","unstructured":"Das B, Jain N, Mallick B (2021) piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair. Commun Biology 4(1):1312","journal-title":"Commun Biology"},{"issue":"8","key":"10040_CR56","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.7150\/ijms.74109","volume":"19","author":"K Ono","year":"2022","unstructured":"Ono K et al (2022) Reproduction of the antitumor effect of cisplatin and cetuximab using a three-dimensional spheroid model in oral cancer. Int J Med Sci 19(8):1320","journal-title":"Int J Med Sci"},{"key":"10040_CR57","doi-asserted-by":"crossref","first-page":"103259","DOI":"10.1016\/j.dnarep.2021.103259","volume":"109","author":"N Jain","year":"2022","unstructured":"Jain N, Das B, Mallick B (2022) Mir-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux. DNA Repair 109:103259","journal-title":"DNA Repair"},{"issue":"12","key":"10040_CR58","first-page":"955","volume":"68","author":"M Zhan","year":"2013","unstructured":"Zhan M et al (2013) Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. Die Pharmazie-An Int J Pharm Sci 68(12):955\u2013961","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"key":"10040_CR59","doi-asserted-by":"crossref","first-page":"101534","DOI":"10.1016\/j.tice.2021.101534","volume":"72","author":"Y Shi","year":"2021","unstructured":"Shi Y et al (2021) MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Tissue Cell 72:101534","journal-title":"Tissue Cell"},{"key":"10040_CR60","doi-asserted-by":"crossref","first-page":"896099","DOI":"10.3389\/fmolb.2022.896099","volume":"9","author":"S Mustafa","year":"2022","unstructured":"Mustafa S, Koran S, AlOmair L (2022) Insights into the role of matrix metalloproteinases in cancer and its various therapeutic aspects: a review. Front Mol Biosci 9:896099","journal-title":"Front Mol Biosci"},{"key":"10040_CR61","doi-asserted-by":"crossref","unstructured":"Hong L et al (2016) miR-125b inhibited epithelial\u2013mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. OncoTargets and therapy, : pp. 2639\u20132648","DOI":"10.2147\/OTT.S102713"},{"issue":"2","key":"10040_CR62","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/jcb.27568","volume":"120","author":"T Xiao","year":"2019","unstructured":"Xiao T et al (2019) MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK\u2010STAT3 pathway. J Cell Biochem 120(2):2616\u20132626","journal-title":"J Cell Biochem"},{"issue":"39","key":"10040_CR63","doi-asserted-by":"crossref","first-page":"64109","DOI":"10.18632\/oncotarget.11627","volume":"7","author":"O Karicheva","year":"2016","unstructured":"Karicheva O et al (2016) PARP3 controls TGF\u03b2 and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Oncotarget 7(39):64109","journal-title":"Oncotarget"},{"issue":"6","key":"10040_CR64","doi-asserted-by":"crossref","first-page":"BSR20170658","DOI":"10.1042\/BSR20170658","volume":"37","author":"W Xiao","year":"2017","unstructured":"Xiao W et al (2017) Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K\/Akt\/mTOR signaling pathway. Biosci Rep 37(6):BSR20170658","journal-title":"Biosci Rep"},{"issue":"11","key":"10040_CR65","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1101\/gad.888501","volume":"15","author":"C Tournier","year":"2001","unstructured":"Tournier C et al (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15(11):1419\u20131426","journal-title":"Genes Dev"},{"issue":"10","key":"10040_CR66","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1074\/jbc.273.10.5423","volume":"273","author":"Y Wang","year":"1998","unstructured":"Wang Y et al (1998) Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 273(10):5423\u20135426","journal-title":"J Biol Chem"},{"issue":"4","key":"10040_CR67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cas.12380","volume":"105","author":"H Sakai","year":"2014","unstructured":"Sakai H et al (2014) MKK 7 mediates mir-493\u2010dependent suppression of liver metastasis of colon cancer cells. Cancer Sci 105(4):425\u2013430","journal-title":"Cancer Sci"},{"key":"10040_CR68","doi-asserted-by":"crossref","unstructured":"Zhang S et al (2018) LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via mir-211-5p mediated Ezrin\/Fak\/Src signaling, vol 9. Cell death & disease, p 742. 7","DOI":"10.1038\/s41419-018-0793-5"},{"issue":"4","key":"10040_CR69","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3892\/mmr.2017.6233","volume":"15","author":"TZ Yuan","year":"2017","unstructured":"Yuan TZ et al (2017) microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2. Mol Med Rep 15(4):2223\u20132228","journal-title":"Mol Med Rep"},{"key":"10040_CR70","doi-asserted-by":"crossref","first-page":"1096882","DOI":"10.3389\/fonc.2023.1096882","volume":"13","author":"C Gobin","year":"2023","unstructured":"Gobin C et al (2023) Investigating miR-9 as a mediator in laryngeal cancer health disparities. Front Oncol 13:1096882","journal-title":"Front Oncol"},{"issue":"1","key":"10040_CR71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cancers12010224","volume":"12","author":"SY Tam","year":"2020","unstructured":"Tam SY, Wu VW, Law HK (2020) JNK pathway mediates low oxygen level induced epithelial\u2013mesenchymal transition and stemness maintenance in colorectal cancer cells. Cancers 12(1):224","journal-title":"Cancers"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10040-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:45:28Z","timestamp":1738730728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10040-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10040"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10040-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1107"}}